Plexus Corp.'s SEC filings document operating results, financial condition, governance matters and material corporate events for its complex product design, manufacturing and services business. Recent 8-K reports furnish quarterly and fiscal-year earnings releases and related financial information for the company's product lifecycle operations across regulated end markets.
The filings also record shareholder meeting results, including director elections, advisory executive compensation votes and auditor ratification, as well as officer transition and compensation-arrangement disclosures. These records describe formal governance actions, executive roles and recurring public-company reporting obligations for PLXS.
Form 144 filing reporting insider sale activity. The filing lists securities to be sold including 1,521 and 1,749 Performance Stock Units with grant dates 02/16/2022 and 02/11/2025. It discloses a sale by Angelo M. Ninivaggi of 2,298 common shares on 05/07/2026 for $604,340.22.
Filer submitted a Form 144 notice proposing the sale of Common Stock of PLXS. The filing lists an intermediary Fidelity Investments at 245 Summer St, Boston and shows a Nasdaq listing with a filing date of 05/08/2026. The excerpt also lists prior stock awards to Michael V. Schrock dated 01/29/2025, 01/30/2024, 01/31/2023 and 01/25/2022 with respective award counts.
Form 144 filing for PLXS: notice of proposed sale of common stock. The filing lists transactions tied to restricted stock vesting under a registered plan and performance stock units, showing 1,771 and 527 shares respectively with grant/vesting dates 01/21/2022 and 02/16/2022. The broker/custodian is Morgan Stanley Smith Barney LLC, and the filing date shown is 05/07/2026.
Plexus Corp. delivered strong growth for the quarter ended April 4, 2026. Net sales rose to $1.16 billion from $980.2 million, an 18.7% increase, driven by higher demand across AMER, APAC and EMEA regions and all three market sectors.
Net income increased to $49.8 million from $39.1 million, with diluted EPS up to $1.82 from $1.41. Gross margin edged up to 10.2% and operating margin to 5.3%, helped by higher volumes and favorable mix despite higher fixed and compensation costs.
Cash generation weakened as operating cash flow fell to $13.1 million from $90.3 million, largely due to higher inventories and other working capital uses, resulting in free cash flow of negative $34.6 million. The company ended with $303.2 million in cash and $234.1 million of debt and spent $43.0 million repurchasing 262,092 shares, with $42.0 million remaining under its current buyback authorization.
PLXS insiders filed Form 144 reporting proposed/respective sales of Common Stock and Performance Stock Units. The excerpt lists multiple recent dispositions: 3,000 shares on 05/05/2026 for $805,350.00, 2,403 shares on 05/04/2026 for $634,139.00, and earlier sales in 2026.
The filings identify the sellers as Todd P. Kelsey and Kelly M. Liv (trust/individual) and record the security type as Common and Performance Stock Units.
Plexus Corp President & CEO Todd P. Kelsey reported open-market sales of 6,403 shares of Plexus common stock in several transactions from May 4–6, 2026, at prices ranging from $263.00 to $270.75 per share. Following these sales, he directly owns 73,888 shares of Plexus common stock.
PLXS reported proposed sales of Common stock via Form 144. The filing lists 3,000 shares tied to Performance Stock Units dated 11/13/2024. The filing also discloses recent dispositions in the past three months, including sales of 2,403, 1,500, 1,500, and 5,231 shares on 05/04/2026, 04/15/2026, 03/18/2026, and 02/18/2026, respectively, with dollar amounts shown for each transaction.
The issuer filed a Form 144 disclosing proposed sales of Common Stock. The filing lists 3,815 shares to be sold by a 401(k) savings plan, and shows a prior sale by Patrick Jermain of 2,321 shares on 02/12/2026 for $466,806.25. Trading venue is NASDAQ.
Todd P. Kelsey reported the sale of Common stock under Rule 144 through Morgan Stanley Smith Barney LLC. The filing lists sales of 5,231 shares on 02/18/2026 for $1,024,111.55, 1,500 shares on 03/18/2026 for $291,360.00, and 1,500 shares on 04/15/2026 for $336,130.05. Broker information shows Morgan Stanley Smith Barney LLC and the securities are Common shares associated with the NASDAQ listing.
Vanguard Capital Management reports beneficial ownership of 1,400,048 shares of Plexus Corp common stock, representing 5.22% of the class as of 03/31/2026. The filing states Vanguard has sole dispositive power over 1,400,048 shares and sole voting power for 201,847 shares. The Schedule 13G is signed by Ashley Grim on 04/30/2026.